GlaxoSmithKline (GSK) turns over P1-M worth of medicines to GMA Kapuso Foundation.
In line with its mission to help people do more, feel better, and live longer, GSK, through its Value Health Program, recently donated medicines for common bacterial infections such as bronchitis and tonsillitis to the GMA Kapuso Foundation. By supporting the Foundation’s regular medical and healthcare missions nationwide, GSK hopes to reach more Filipinos in need of these essential medicines. Launched in 2004, the Value Health program offers significant price reductions for GSK’s original branded medicines that treat common ailments and was established in response to Filipinos’ need for improved access to high quality and affordable medicines. Present during the turnover were GSK Vice President for Value Health Daisy Cembrano (left) and Ms. Christina Betonio, Project Manager for GMA’s Kapuso Foundation.
Back to top
GSK at a glance
We are the only pharmaceutical company to tackle the three "priority" diseases identified by the World Health Organization: HIV/AIDS, tuberculosis and malaria Our business employs over 100,000 people in 117 countries We make almost four billion packs of medicines and healthcare products every year We screen about 65 million compounds every year in our search for new medicines We supply one quarter of the world's vaccines and by the end of 2007 we had 23 vaccines in clinical development To date, we have donated over 750 million albendazole tablets to help elimitate lymphatic filariasis (elephantiasis) in the world In 2006 we shipped 126 million tablets of preferentially-priced Combivir and Epivir (our HIV treatments) to developing countries Almost 100 countries benefitted from our humanitarian product donations